soblidotin

DRUG3 trials

Sponsors

Daiichi Sankyo, Daiichi Pharmaceuticals

Conditions

Lung CancerSarcomaUnspecified Adult Solid Tumor, Protocol Specific

Phase 1

Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

WithdrawnNCT00072228

Daiichi PharmaceuticalsUnspecified Adult Solid Tumor, Protocol Specific

Updated: 2013-07-10

Phase 2

Soblidotin in Treating Patients With Progressive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

CompletedNCT00061854

Daiichi SankyoLung Cancer

Start: 2003-04-30End: 2005-05-31Updated: 2012-05-16

Soblidotin in Treating Patients With Advanced or Metastatic Soft Tissue Sarcoma

CompletedNCT00064220

Daiichi SankyoSarcoma

Start: 2003-04-30End: 2005-12-31Updated: 2012-05-16